Abstract Formation of PrP aggregates is considered to be a characteristic event in the pathogenesis of TSE diseases, accompanied by brain inXammation and neurodegeneration. Factors identiWed as contributing to aggregate formation are of interest as potential therapeutic targets. We report that in vitro proteolysis of ovine PrP . This implies an important structural contribution of the 1 sequence within the globular domain of PrP. We propose that the removal or detachment of the 1 sequence enhances -oligomer formation from the globular domain, leading to aggregation. The cellular implications are that speciWc proteases may have an important role in the generation of membranebound, potentially toxic, -oligomeric PrP species in preamyloid states of prion diseases. Such species may induce cell death by lysis, and also contribute to the transport of PrP to neuronal targets with subsequent ampliWcation of pathogenic eVects.
Introduction
The prion protein (PrP) is a key molecule in transmissible spongiform encephalopathies or prion diseases, (reviewed in Prusiner 1998) . However, the precise mechanism of the transformation in vivo of the normal -helical containing cellular form (PrP c ) to a highly associated -structured form, identiWed by FTIR (Pan et al. 1993) , and typiWed in many diseased states by characteristic deposits, such as the toxic scrapie form, PrP Sc , is still unknown (Caughey and Baron 2006) . Extensive biophysical work has demonstrated the conformational conversion of recombinant PrP from -to -forms under a variety of in vitro solution conditions that include low pH, denaturants, salts and detergents, often with prolonged mechanical agitation. These treatments result in the formation of -oligomers and in some cases, amyloid Wbril structures. (e.g: Swietnicki et al. 2000; Morillas et al. 2001; Baskakov et al. 2001; Baskakov et al. 2002; Rezaei et al. 2005) . Aggregated Wbrillar forms of recombinant PrP ('synthetic prions' Legname et al. 2004) ) have been shown to cause disease in animal models; however, the demonstration of the toxicity of oligomeric forms of PrP derived from PrP Sc (Silveira et al. 2005) indicates that certain non-amyloidal forms are also potentially toxic.
Many prion diseases associated with natural and transgenically expressed PrP mutants involve a very slow development (Prusiner 1998) . By contrast, it has been shown that the expression in transgenic PrP o/o mice of PrP c containing deletions of amino acids 32-134, 94-134 or 105-125 creates unexpectedly severe neuropathological phenotypes. These include ataxial behaviour and myelin vacuolar degeneration of the brain, occurring without detectable deposition of the typical protease-resistant PrP Sc deposits characteristic of the scrapie condition, (Shmerling et al. 1998; Baumann et al. 2007; Li et al. 2007 ). The molecular basis of this neuropathology, and its suppression by coexpression of normal PrP c , is also unknown. These results indicate a potential role for proteolysed forms of PrP in certain prion disease mechanisms. Intra-and extracellular proteases have been shown to be of potential importance in the modiWcation of neuronal receptors (Saito and Bunnett 2005) and development of prion diseases (Parkin et al. 2007; Yadavalli et al. 2004) , and abnormal traYcking, folding and targeting of the cellular protein have been implicated in prion pathogenesis (Tatzelt and Schatzl 2007) .
In this work we examine the conformational consequences of proteolysis of PrP by members of a ubiquitous family of proteases, the cathepsins, which exhibit wide-ranging cellular functions [Turk et al. 2000] . Cathepsin S is a cysteine protease that is able to work outside the lysosome and in a wide range of pH; it is secreted by microglia and over-expressed in scrapie brain (Baker et al. 1999; Xiang et al. 2004) . We examine the eVects of in vitro proteolysis of PrP by cathepsin S, and show that it causes speciWc and limited N-terminal truncation of PrP . This induces an unusually eYcient, protein concentration dependent, ! conformational conversion, initially forming a soluble -structured intermediate species, that leads to thioXavin T-positive PrP aggregated species. Sequence analysis of the proteolytic fragments shows a striking similarity between these truncated species and the PrP variants of known high toxicity in PrP o/o transgenic mice, (Shmerling et al. 1998; Baumann et al. 2007; Li et al. 2007) . Recombinant expression of the proteolytic fragments shows that the absence of sequences including the 1 residues results in decreased stability and solubility of the PrP globular domain. This suggests proteases may act as a general trigger mechanism for the formation of -structured oligomeric forms under physiological conditions, and indicates a potential role of proteolytic processes in contributing to rapid toxicity and to longer-term prion pathogenesis.
Experimental

Protein expression and puriWcation
The hexa-His tagged ovine PrP 94-233 (ARQ allele) was expressed and puriWed as described (Haire et al. 2004 ) with small modiWcations. The cell lysate was centrifuged at 20,000g for 20 min. The resulting pellet was dissolved in buVer A (10 ml per 1 g of pellet; 100 mM Tris (pH 8.0), 8 M Urea), incubated for 2 h at room temperature, and centrifuged at 20,000g for 15 min to remove insoluble material. The solubilized inclusion bodies were incubated with Ni-NTA Agarose (Qiagen) at 4°C for 1 h on a rocker table. The NTA column was washed to remove unbound protein with Wve volumes of buVer A. Refolding of PrP was achieved with PrP still bound to the resin by resuspending the pelleted resin in cold refolding buVer (50 mM Tris, pH7.5). This mixture was incubated for 30 min at 4°C with rocking. PrP was eluted from the resin in refolding buVer supplemented with 500 mM imidazole pH 7.5, and dialyzed against 50 mM sodium acetate (pH 5.5). The purity of the Wnal rPrP preparation was conWrmed by SDS-PAGE, and far UVCD spectroscopy was used to conWrm the correctly folded structure. Protein concentration was determined on the Jasco V550 spectrophotometer, with a calculated 280 for OvPrP 94-233 of 23,505 M ¡1 cm
¡1
. OvPrP 138¡233 , PrP 144-233 and PrP 156-233, were similarly expressed, but with a protease-sensitive His tag that is removed either in the NTA-attached state, or following the imidazole elution step. Prolonged storage of PrP in Tris buVer was avoided, since it causes degradation.
Circular dichroism spectroscopy and analysis CD experiments were performed at 30°C in 50 mM MES at pH 5.5-6.5 with protein concentrations 6-60 M in a 1 or 0.2 mm (demountable) cuvette. CD spectra were recorded from 260 to (maximally) 190 nm on a Jasco J-715 spectropolarimeter at 20 nm/min with bandwidth 2.0 nm. 25 CD scans were averaged, smoothed by instrumental software and the data expressed as CD extinction coeYcient, mrw (M ¡1 cm ¡1 ) . CD spectra were analysed by the method of CONTIN, (Provencher and Glockner 1981) , using the set of spectra of 48 proteins, SD48, that includes Wve denatured proteins, (Sreerama and Woody 2000) . Data were smoothed with standard polynomial procedures; truncation of data to 205 nm did not signiWcantly aVect the numerical analysis results. In all cases the curve Wtting was within the experimental noise level of the accumulated spectrum. The numerical results for composition in terms of -helix, -sheet, turns and aperiodic (coil) structure were fully consistent with those from analysis by alternative analytical methods. Unfolding studies were performed with heating rate 1°/min, and cooling rate (for PrP ) 2°/min.
Digestion of PrP by cathepsin S and other proteolytic enzymes
The PrP 94-233 (20-60 M) was treated with cathepsins S L or D at 30°C at diVerent weight ratios of prion protein to enzyme in aqueous buVer at pH 5.5-7.5, containing 0.2 mM DTT and 0.2 mM EDTA. The digestion was carried out in 100 l volume in 96-well plates (SaWre 2, TECAN) in the presence of 100 M ThT, (Breydo et al. 2005) . The plate was sealed with ImmunoWare tape. The kinetics were monitored by bottom reading of Xuorescence intensity every 10-15 min using monochromator settings of 444 nm excitation and 485 nm emission and 5 nm bandpass, which were shown to ensure Xuorescence was monitored with full exclusion of possible light scattering artefacts. Digestion of PrP 94-233 by calpain-1 was performed in aqueous buVer, pH 5.5 containing 1 mM Ca 2+ and 0.2 mM DTT. Stock solutions were diluted as indicated. All proteases were from Merck.
Mass spectrometric analysis ESI-MS (electrospray ionization mass spectrometry) was used to analyze the soluble products of PrP after 10 min digestion of PrP (160 M) with cathepsin S (0.1 M) at room temperature in 50 mM sodium acetate (pH5.5).
N-terminal protein sequence analysis and Western blot PrP 94-233 (100-160 M) was digested by cathepsin S (0.06-0.1 M) under standard conditions in Eppendorf tubes. The proteolytic products were analyzed during the time course over a period of 24 h. For N-terminal sequencing, aliquots of the digestion mixture were heated at 95°C for 15 min and analyzed by SDS-PAGE (4-12% NuPage Mes system : Invitrogen) under non-reducing conditions, and blotted onto Immobilon PSQ PVDF membrane (Millipore) . N-terminal sequencing was performed by the PNAC Facility, (University of Cambridge). For Western blot experiments, protein bands were electro-blotted onto the membrane, incubated with anti-PrP mAb AH6 (1 g/ml) (IAH, Compton, UK) followed by incubation with donkey anti-mouse IRQye800 conjugate (1:5,000 dilution, Rockland) and Xuorescent detection on Odyssey ® Imaging System (Li-Cor Biotechnology).
Proteinase K digestion
The pelleted material after digestion of PrP 94-233 (0.5 mg/ ml) by cathepsin S was treated with Proteinase K (Qiagen) in 50 mM Tris (pH 7.5) at 37°C, using diVerent weight ratios of PrP to PK. Aliquots were removed over a period of 48 h and digestion was stopped by quenching with 2 mM PMSF plus 4 £ SDS sample buVer, with SDS-PAGE analysis as above.
Results
Plate reader Xuorescence assay of PrP aggregation
The time course of digestion of PrP 94-233 by cathepsin S, (studied in a 96-well plate format (Breydo et al. 2005) , showed a progressive increase in ThT Xuorescence with a characteristic lag phase and eventual attainment of a plateau, correlating with production of aggregated material. Figure 1a -d shows that increased concentrations of either cathepsin S or PrP diminishes the lag phase and increases the plateau value. Similar behaviour is seen from pH 5.5 to 7.5. This corresponds to the pH range encountered in normal plasma conditions as well as the internal pH of vesicles. At the higher pH values, and with increased concentration of cathepsin S, the plateau eventually decreases, correlating with the digestion of the aggregated material.
Analysis of proteolytic fragments
The time-dependent evolution of the products of the digestion of PrP by cathepsin S at ratio 1:1,500, was analysed on non-reducing SDS PAGE gels for the total digestion mixture, Fig. 2a and for the precipitate and supernatant separated by centrifugation, (Fig. 2b, c) . The precipitate and supernatant account for all the bands observed in the total digest. No precipitate was observed at time zero, but became evident at approximately 3 h, increasing thereafter, Fig. 2b . Soluble PrP fragments are identiWed from t = 30 min onwards in bands 3,4,5,6 and 7, Fig. 2c . The gels were blotted for N-terminal sequencing of the numbered bands, and the relative amounts of the diVerent proteolytic fragments are presented in Table 1 . N-terminal analysis shows that the precipitate (band 1-2, Fig. 2b ) is composed of fragments with N-terminal sequences 135SAMS and 144FGND in similar quantities. Fragments in the supernatant (bands 4-7) correspond to 135SAMS and shorter sequences, and the fastest band which contains the N-terminal His tag sequence of the recombinant PrP .
An initial mass spectrometry analysis of the digestion mixture identiWed three major soluble fragments PrP 135-233, PrP 117-233 , and PrP 114-233, (data not shown). Also, on reducing gels, all bands (except band 3, which was absent) behaved identically. These two results indicate that no proteolytic cleavage of PrP 94-233 has occurred between Cys 182 and the C-terminus, Ala 233 , (since this would have led to a band of lower mass on the reducing gel) and aggregation does not involve intermolecular disulphide exchange (since pronounced diVerences would have been observed with the non-reducing gel). The soluble band 3 also contains the His tag, and is apparently a disulphide linked PrP species, attributable to the presence of 0.2 mM DTT required to maintain cathepsin activity. It is also seen as a minor species in the absence of cathepsin S, (control, Fig. 2b ). At higher ratios of cathepsin S, the 144FGND fragment constitutes a larger proportion of the insoluble precipitate, approaching equivalence with 135SAMS. Thus the presence of 144FGND in the digest correlates with the appearance of aggregation.
Cleavage patterns of PrP with other proteases N-terminal sequence analysis of these bands was used to identify the cleavage patterns of PrP with several cathepsins and calpain-1, which are summarized in Fig. 3 . Of these enzymes, cathepsin B and calpain-1 yield soluble fragments whereas cathepsins S and L are most eVective in producing ThT-positive aggregates. Cathepsin S shows major cleavage sites at 135SAMS and 144FGND, associated with aggregation. Cathepsin L has three main cleavage sites and produces a precipitate with 135SAMS, 144FGND and 146NDYE in similar amounts, together with signiWcant amounts of shorter species 160YPNQV and 167RPVDQ. Calpain-1 shows major cleavage sites at 120AAGA and 135SAMS, but does not lead to aggregate formation on the same time scale as cathepsin S. Hence cleavage beyond 135SAMS appears to increase the yield of aggregates.
Properties of the aggregated material
A major characteristic of PrP Sc , the disease-associated, aggregated form of PrP, is its increased resistance of the protein to digestion by the bacterial proteinase K (PK). Compared with amyloid Wbrils prepared in vitro (Baskakov et al. 2002) , the resistance of the pelleted material from the cathepsin S digestion was signiWcantly reduced (data not shsown). Optical and electron microscopy of the products identiWed in the ThT assay showed mainly the presence of associations of approximately spherical aggregates, rather than amyloid Wbrils (see Supplementary Material, Figure  S1 ).
Structural changes of PrP during cathepsin S proteolysis
Monitoring the time course of the digestion process continuously by far UV circular dichroism shows that the conformational consequences are dependent on the protein concentration. Figure 4a , with (PrP) = 9 M, shows the progressive and extensive loss of the typical -helical content of PrP 94-233 , ( = 38%, = 14%, turn = 19%, coil = 29%) with conversion to a largely random coil form Table 1 Approximate relative amounts of diVerent fragments produced by digestion of PrP 94-233 by cathepsin S, determined by N-terminal sequence analysis
Relative amounts of material analysed in bands 1-2 (precipitate, from Fig. 2b ) and for bands 3-7 (supernatant Fig. 2c ), the total amount (pmoles), and the percentage of a given fragment. Fragments are denoted by the initial sequence of three residues. The GHH fragment represents a sequence with the intact N-terminal tag, apparently a dimeric PrP species in the minor band 3 of the supernatant. The control (Fig. 2) shows a minor contamination of this species in the absence of digestion, probably due to the low concentration of DTT present in the buVer in order to maintain the protease activity Sequence  GHH  HVA  GAA  GLG  GYM  135SAM  DYE ( = 11%, = 13%, turn = 17%, coil = 59%). By contrast, with (PrP) = 60 M, there is a progressive conversion of the spectrum of the -helical form to one with a single negative trough at 215 nm, typical of -structured species, Fig. 4b . Analysis shows the Wnal conformation ( = 9%, = 33%, turn = 24%, coil = 34%), indicating a substantial loss of -helix and a predominantly ! conformational transition. During the digestion period, under both conditions, there was no evidence of CD signal distortion above 195 nm from light scattering, and no turbidity was detectable by visual inspection. The spectrometer dynode voltage remained constant at 364.3 § 1.1 for A, and 374.2 § 1.2 for B, indicating the constancy of the optical transmission of the samples. This demonstrates that in both cases, the initial digestion product did not precipitate under the conditions of the CD experiments. The concentration dependence of this ! transition indicates that molecular association occurs at the higher concentration, with formation of a soluble -structured intermediate that precedes the aggregation process. The time course of the CD changes are similar in both cases (Fig. 4c) with the presence of a lag phase indicating that the conformational eVects are dependent on the initial proteolysis, and that the oligomeric molecular association at the higher concentration is relatively rapid. Control experiments of PrP 94-233 digested with calpain-1 show a slower decrease of -helix and gain of both and (turn + coil) conformational components (data not shown). However, in contrast to the cathepsin S experiments, no aggregation was observable in digestion with calpain-1 in the plate assay even after several days incubation.
Stability studies
In order to further characterize the conformational diVerences between Prp 94-233 and its N-terminal truncations, the sequences PrP 138-233 , PrP 144-233 and PrP 156-233 were expressed and puriWed, and their thermal stability compared to that of PrP 94-233 was examined by far UV circular dichroism. All showed decreased solubility and a tendency to slow aggregation in Tris pH 7.5, buVer, but, at low concentration, all species showed a single thermal unfolding transition, Fig. 5a . This was only partially reversible on cooling, (»50% for PrP and 20% for the shorter fragments), with visible turbidity. All fragments were signiWcantly more soluble in 1 M GuHCl, without signiWcant loss of normal -helical secondary structure. EVectively fully (>95%) reversible thermal unfolding was observed PrP Fig. 5b . These results indicate a signiWcant discontinuous loss of thermodynamic stability of these species lacking N-terminal residues preceding -helix 1. This sequence includes the short 1 seqeunce (MLG,132-134) that engages in antiparallel, intramolecular interaction with 2, (QVY,163-165). The near UV CD of PrP shows that the conformation of aromatic side-chains is signiWcantly aVected by the presence of 1 M GuHCl, Fig. 5c . (Ov)PrP 94-233 contains a single Trp residue (W102) in a region that appears unstructured in both NMR and crystallographic studies (Haire et al. 2004) , plus 12 Tyr residues, which are located in two clusters within the globular domain linked by helix 3, and which include three Tyr-Tyr dipeptide repeats. The diVerence spectrum (Fig. 5c) has the form of a CD 'couplet', with positive and negative lobes, consistent with electronic interactions amongst the Tyr residues being at least partially disrupted in 1 M GuHCl. The perturbation of tertiary structure with unchanged secondary structure is typical of a molten globule conformation. This state has recently been proposed for the -rich oligomeric form of PrP (O'Sullivan et al. 2007) , and for an intermediate conformational precursor (Gerber et al. 2007 ), both observed under mildly denaturing and low pH conditions in vitro. Interestingly, the use of 1 M GuHCl has been the basis of several in vitro conformational conversion assays for PrP (Caughey et al. 1999) , and partially denaturing conditions involving low pH, GuHCl, urea and salt, plus mechanical agitation) are well established means of generating Prp amyloid Wbrils (Morillas et al. 2001; Baskakov et al. 2002) . We conclude that loss of the -1 sequence by proteolysis under more normal neutral solution conditions causes a signiWcant conformational perturbation of the globular domain of Prp, leading to -transformation, accompanied by oligomerisation of the state.
Discussion
Previous extensive studies have illustrated the ability of several unstructured peptide fragments of PrP to adopt -structure and to form insoluble Wbrils, often at low pH, mimicking the conditions of the endosomal compartment, (Tagliavini et al. 2001; Jamin et al. 2002) . In fact the short sequence PrP 172-178 is closely related to the Sup35 heptapeptide that has been shown to form a -structured polar zipper, (Nelson et al. 2005; Sawaya et al. 2007 ). In addition, the mixtures of digestion products of PrP with common non-physiological proteases have been shown by dynamic light scattering to produce large aggregates in a time-dependent process, (Georgieva et al. 2004) . No correlation has been established to date between such short fragments and potential pathogenicity in prion diseases. However these results indicate a number of possible candidates for initiation of -structure formation in PrP, or alternatively that, once initiated, -structure can become the predominant conformation for a large fraction of the sequence, possibly limited by the persistence of the intramolecular disulphide bond.
We show by N-terminal sequence analysis that the region of PrP between S135 and N146 is a major target for selective cleavage cathepsins S and L. The proteolysis by calpain-1 produces mainly 135SAMS, but without aggregation on the same time scale. We deduce that the shorter fragment, 144FGND, apparently formed from, or in parallel with, 135SAMS by cathepsin S, is an eYcient promoter of this aggregation step. Monitoring of the cathepsin Sdependent assembly process by ThT Xuorescence and of protein conformation by far-UV CD indicates the initial formation of a soluble form of proteolysed PrP species that loses much of the -helical structure (initially»38%), and adopts a conformation with a signiWcantly increased proportion (»33%)of -structure. The structural mechanism whereby proteolysis leads to this conformational conversion involves cleavage of the globular domain PrP in the region of residue S135, leading to more extensive proteolysis by cathepsin S. In the intact globular domain, (with helices 2 and 3 linked by the disulphide bridge), the helices 1-3 form the stable core of the globular domain with the lowest degree of thermal motion (Haire et al. 2004 ), 1 and 2 strands form the shortsheet, and residues 134 to 137 are relatively mobile. The thermal stability studies show that sequences lacking the 1 strand are signiWcantly less stable than PrP , and are more prone to aggregation. In the absence of 1, the detachment of the relatively mobile extended sequence (135-144) prior to -helix H1 could give access to the cathepsin-speciWc site prior at 144F, and the proteolytic release of residues up to 144F exposes several hydrophobic residues. The formation of the 144FGND fragment by cathepsin S promotes the formation of the strongly ThTpositive aggregated form containing both 135SAMS and 144FGND. The far UVCD data indicate that the species initially formed with enhanced intermolecular -structure are soluble and hence are conformational precursors of the aggregated state.
The destabilisation of the core of the globular domain by proteolysis in the region between the secondary structural elements 1 and -helix H1 is consistent with previous conformational studies on two N-terminal deletion/truncation mutants of mouse PrP globular domain 121-231, mutant H1 with H1 replaced by a short -turn, and mutant H2H3, MoPrP , that lacks 1, but contains the two last helices, (Eberl and Glockshuber 2002) . Both mutants are signiWcantly destabilized relative to the globular domain (MoPrP 121-231 ). Both retain some -helical structure, but, consistent with the present Wndings, mutant H2H3 is the less stable. The extensive conformational conversion on proteolysis of PrP by cathepsin S observed by far UVCD must involve a substantial fraction of the residues of the PrP globular domain, and this conformational conversion is further driven by intermolecular association to produce the soluble oligomeric intermediate.
The key role of the 1 sequence as shown by the proteolysis results suggets a consistent molecular mechanism for the generation of extensive -sheet structure of PrP under diVerent conditions. Denaturants and detergenets at concentrations less than those required to cause equilibrium unfolding of the globular domain could also aVect the stability of the 1-2 interaction. Low pH could act similarly as shown by molecular dynamic simulation (Alonso et al. 2001) . The sequence immediately following 1 shows high thermal factors in the crystal structure and mobility in NMR properties (Haire et al. 2004) , indicating only weak interaction with the globular domain. Thus in these cases the disruption of the intramolecular 1-2 sheet by partial denaturation, as with the removal of the 1 sequence by proteolysis, could act as a trigger that initiates the increase of -structure within the domain, leading to self-association and aggregation of the -oligomer.
Cellular implications
The early sites for proteolysis of PrP 94-233 by these cathepsins that result in aggregation occur selectively in the N-terminal region of the globular domain, implying that, in vivo, similarly proteolysed PrP c would retain its GPI anchor and thus would remain attached to the plasma membrane. This suggests the possibility that such a membrane bound proteolytically N-truncated PrP could concentrate locally and self-associate to form -rich intermediates of PrP under physiological conditions that could act as nuclei for the longer-term formation of higher oligomers. In addition, as reported for the toxicity of oligomers of a number of amyloidogenic sequences, they could themselves act as potent pathogenic lytic agents, (Kayed et al. 2004; Walsh and Selkoe 2007) . The CD analysis shows that a key factor in the ! conformational conversion of PrP is the local concentration of the destabilised proteolytic fragment. When the fragment is expressed in a Prp o/o mouse, it would presumably be at relatively high local concentration at the plasma membrane, and could be toxic per se, or rendered so by very limited proteolysis and aggregation. In the presence of co-expressed wt-Prp, known to abrogate the rapid neonatal pathogenesis, the local concentration of the fragment would be reduced, and conversion or toxicity would be signiWcantly retarded.
Current knowledge (Silveira et al. 2005; Tatzelt and Schatzl 2007) suggests that prion diseases may reXect a multiplicity of distinct but not necessarily exclusive mechanisms. Theserelect phenomena observed on widely diVerent time-scales. On the one hand, the transmissibility of an 'infectious' form of PrP, is characterized by the progressive but slow appearance of a proteinase K-resistant aggregated form (PrP Sc ) containing enhanced -structure possibly generated in an endosomal low pH environment. Alternatively the involvement of various mutated, truncated and deleted PrP variants can lead to pathogenic phenotypes, that, in view of their potency, act too rapidly to allow accumulation of the PrP Sc species. The striking Wnding of our work is that cathepsin proteases, normal physiological enzymes that are also associated with pathogenic conditions, readily generate speciWc fragments of PrP 94-233 with a clear and striking sequence similarity to deletion and truncation mutants of PrP, modiWed in the region of sequence 1, that are highly toxic when expressed transgenically, (Baumann et al. 2007; Li et al. 2007 ). In addition, the eYcient formation ofstructured PrP oligomers by proteolysis implies a potential role in the early stages of certain pathogenic conditions. However the existence of numerous disease-related point mutations and associated variants throughout the PrP sequence (Prusiner 1998) indicates that other regions of PrP exert important inXuences throughout the development of the pathogenic responses. It could be highly informative to assess the relative contributions of these factors using experimentally generated PrP variants with mutations to key residues within the protease sensitive regions to prevent proteolysis.
Extracellular proteases have been implicated in both physiological and pathological states in the central nervous system. Some play a crucial role in neuronal migration, neurite outgrowth and synaptic plasticity. Others are required for neuronal death and tumour growth and invasion. Various insults can disrupt the Wne control of proteolysis and cause pathological changes (Zhang et al. 2005) . Cathepsin S is able to work outside the lysosome and in a wide range of pH. It is especially expressed in cells of a mononuclear lineage including microglia. Gene knock-out results have revealed that cathepsin S and other cathepsins carry out their speciWc functions by limited proteolysis of proteins (Turk et al. 2000) . There is increasing evidence that disturbance of the normal balance of cathepsins contribute to neurodegeneration (Nakanishi 2003) . One of the recently discovered functions of cathepsin S in the brain is its role in the migration and activation of microglia to protect motor neurons against injury, (Hao et al. 2007 ). It was shown that cathepsin S releases a soluble chemokine FLK from the cellular surface of some neurons that is able to stimulate microglia to secrete speciWc soluble mediators of neuronal activity (Clark et al. 2007 ). New data demonstrate that cathepsin S is also involved in some important pathological events including Alzheimer and prion diseases. The activation of cathepsins was found to be an upstream event in the experimental scrapie model (Xiang et al. 2004 ). The ME7 model of murine prion disease shows an atypical inXammatory response characterized by morphologically activated microglia and an anti-inXammatory cytokine proWle with a marked expression of TGF-1 (Baker et al. 1999) . TGF-1 plays a critical role in the down-regulation of microglial responses minimizing brain inXammation and damage caused by reactive oxygen species and extracellular proteases. Up-regulation of cathepsin S and other cathepsins in activated glia may signiWcantly contribute to neurodegeneration. Cathepsin S was found in exosomes released by activated microglia (Potolicchio et al. 2005 ). This observation may provide a mechanism of a fast and speciWc delivery of cathepsin S and other reagents to neurons that could be mediated via exosomes released by activated microglia. The physiological advantage of exosome transport in the brain can be justiWed because this organ, in which cell motility is greatly restricted, needs an integral reliable communication between glia and neurons to support neuronal metabolism and to act quickly in response to brain injury, proinXammatory events and invasion of pathogens. However, exosomes have also recently been reported to be carriers of proteins associated with several amyloid diseases including prion disease (Vella et al. 2007) , and hence transported PrP could also serve to amplify incipient neuropathogenic conditions. It would clearly be of interest to know if there is link between proteolysis, conversion and aggregation process, and the generation and secretion of exosomes. Elevated levels of PrP c expression in the presence of reactive oxygen and nitrogen species, rapid recycling, speciWc proteolysis and signiWcant pH dependent conformational changes suggest that PrP c is able to sense various external stimuli and to transmit conformational changes into intra-and intercellular signals. The loss of the N-terminus may disrupt normal PrP functions and cause the anomalous signalling of truncated protein (Shmerling et al. 1998) . PrP is also very sensitive to other abnormal interactions such as the cross-linking anti-PrP monoclonal antibodies D13 and P that were shown to be highly toxic in in vivo experiments (Solforosi et al. 2004) . These data show that there are multiple ways in which PrP may lose its function and might convert into a toxic form, including the loss of the N-terminus as a result of speciWc proteolytic cleavage.
The in vitro proteolysis studies reported here represent a substantial simpliWcation of the complex physiological system, reduced to the actions and interactions of a small number of puriWed components. In this case we have concentrated on the action on PrP of cathepsin S, in view of its speciWc elevation in conditions of scrapie pathogenesis, though the Wndings would apply to any physiological protease of the requisite speciWcity. Examination of the potential toxicity of the individual fragments identiWed in this work remains to be performed. While experiments on PrP conversion in vitro and in vivo generally relate to very diVerent time scales, the observations of severe and relatively rapid pathogenicity by the transgenic expression of deletion and truncation mutants of PrP correlate with sequences that also show slow aggregation appear to bring the two experimental time domains into closer proximity. The ability of coexpressed wt-PrP c to suppress the pathogenic eVects of the mutant proteins might suggest normal cellular disposal mechanisms can provide only limited protection against a low threshold of toxic products. However, these mechanisms may be insuYcient to counteract the eVects of a localized overload of aggregated material and enhanced protease activity under disease conditions. Understanding of this important protective mechanism would add signiWcantly to the identiWcation of agents highly relevant to the development of therapeutic interventions against prion diseases.
